Sangamo BioSciences | SGMO - Umsatzkosten

Aktienkurs
0.25
Täglich Wechseln
-0.01 -4.09%
Monatlich
-38.64%
Jährlich
-65.04%
Q2 Prognose
0.24




Umsatzkosten Veränderung Datum
Alaunos Therapeutics USD 0 18K 2024-09
Alnylam Pharmaceuticals USD 267.72M 67.57M 2025-12
Amgen USD 1.79B 128M 2025-12
Bayer EUR 4.5B 194M 2025-12
BioCryst Pharmaceuticals USD 9.52M 7.34M 2025-12
Biogen USD 810.1M 205.1M 2025-09
BioMarin Pharmaceutical USD 161.56M 16.62M 2025-12
Cipla INR 29.1B 1.16B 2025-12
Clal Biotechnology ILS 16.49M 2.64M 2022-06
Compugen USD 3.54M 1.89M 2025-12
CSL USD 3.87B 2.08B 2025-12
Gilead Sciences USD 1.62B 50M 2025-12
GlaxoSmithKline GBP 2.61B 377M 2025-12
Grifols EUR 1.51B 184.45M 2025-12
Ionis Pharmaceuticals USD 8M 5.66M 2025-12
J&J USD 7.97B 689M 2025-12
Karyopharm Therapeutics USD 1.48M 35.95M 2025-12
Merck USD 3.32B 531M 2025-12
Novartis USD 3.54B 3M 2025-12
Omeros USD 33.16M 18.52M 2024-06
Pfizer USD 6.29B 2.12B 2025-12
Roche Holding CHF 8.48B 4.61B 2025-12
Sangamo BioSciences 2.42M 1.11M 2024-06
Sanofi EUR 4.29B 421M 2025-12
Sarepta Therapeutics USD 399.38M 247.93M 2025-12
Ultragenyx Pharmaceutical USD 29M 1.01M 2025-12
Vertex Pharmaceuticals USD 466M 51.2M 2025-12